MTHFR and metabolic syndrome: In our study, we investigated the association of this variant with the metabolic index change induced by antipsychotic treatment, and we found that the MTHFR C allele carriers were more likely to increase BMI among risperidone-treated patients as well as the LDL level of haloperidol-treated patients, which are both risk effects of metabolic syndrome.